All Stories

  1. Efficacy of biologic agents in patients with comorbid asthma and chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials

    Article • European Respiratory Review, January 2026, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  2. Tuberculosis-associated immune reconstitution inflammatory syndrome in a non-immunocompromised patient

    Article • Breathe, October 2025, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  3. Case Report: High efficacy of low-dose flecainide as an add-on therapy to a beta-blocker for treating a high burden of idiopathic ventricular arrhythmias in a juvenile athlete

    Article • Frontiers in Cardiovascular Medicine, May 2025, Frontiers

    Chris Kyriakopoulos

  4. Managing Small Airways Dysfunction in COPD Patients in Real Life Under Fixed Triple Combination of Beclomethasone/Formoterol/Glycopyrronium: The MASCOT Real World Evidence Study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2025, Taylor & Francis

    Chris Kyriakopoulos

  5. Interstitial Lung Abnormalities: Unraveling the Journey from Incidental Discovery to Clinical Significance

    Article • Diagnostics, February 2025, MDPI AG

    Chris Kyriakopoulos

  6. Oscillometry Assesses Small Airway Disease and Reveals Peripheral Lung Pathology in Early Pulmonary Fibrosis: A Cross-Sectional Study

    Article • Diagnostics, December 2024, MDPI AG

    Chris Kyriakopoulos

  7. Effectiveness of anti-IL-5/5Rα biologics in severe asthma in real-world studies: a systematic review and meta-analysis

    Article • ERJ Open Research, September 2024, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  8. Effect of Body Weight on Glycaemic Indices in People with Type 1 Diabetes Using Continuous Glucose Monitoring

    Article • Journal of Clinical Medicine, September 2024, MDPI AG

    Chris Kyriakopoulos

  9. Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials

    Article • European Respiratory Review, April 2024, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  10. Achievement of high-quality home spirometry in patients with asthma: The NuvoAir platform

    Article • Pneumon, November 2023, E.U. European Publishing

    Chris Kyriakopoulos

  11. Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality

    Article • Journal of Clinical Medicine, September 2023, MDPI AG

    Chris Kyriakopoulos

  12. Biologic agents licensed for severe asthma: A systematic review and meta-analysis of randomised controlled trials

    Article • September 2023, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  13. Abstract B016: Liquid biopsy biomarker analysis of a phase II trial of sacituzumab govitecan in castrate resistant metastatic prostate cancer

    Article • Cancer Research, June 2023, American Association for Cancer Research (AACR)

    Chris Kyriakopoulos

  14. Effects of Hypoglycemia on Cardiovascular Function in Patients with Diabetes

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Chris Kyriakopoulos

  15. Recurrent bilateral lung infiltrates in a patient with ulcerative colitis

    Article • Breathe, December 2022, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  16. A hybrid approach based on dynamic trajectories to predict mortality in COVID-19 patients upon steroids administration

    Article • September 2022, Institute of Electrical & Electronics Engineers (IEEE)

    Chris Kyriakopoulos

  17. Mortality of hospitalized COVID-19 patients that were residents of nursing homes

    Article • September 2022, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  18. Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study

    Article • Journal of Clinical Medicine, August 2022, MDPI AG

    Chris Kyriakopoulos

  19. Predicting the need for mechanical ventilation and mortality in hospitalized COVID-19 patients who received heparin

    Article • July 2022, Institute of Electrical & Electronics Engineers (IEEE)

    Chris Kyriakopoulos

  20. Baseline characteristics and outcome predictors in patients hospitalized with COVID-19 in the University General Hospital of Ioannina, Greece

    Article • Pneumon, February 2022, E.U. European Publishing

    Chris Kyriakopoulos

  21. ICU admission and mortality classifiers for COVID-19 patients based on subgroups of dynamically associated profiles across multiple timepoints

    Article • Computers in Biology and Medicine, February 2022, Elsevier

    Chris Kyriakopoulos

  22. The Role of Digital Tools in the Timely Diagnosis and Prevention of Acute Exacerbations of COPD: A Comprehensive Review of the Literature

    Article • Diagnostics, January 2022, MDPI AG

    Chris Kyriakopoulos

  23. Evaluating the Impact of Triple Therapy on Mortality in Copd: The End is the Beginning?

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, January 2022, Taylor & Francis

    Chris Kyriakopoulos

  24. Reply

    Article • Respirology, January 2022, Wiley

    Chris Kyriakopoulos

  25. The Diagnostic Role of Uric Acid to Creatinine Ratio for the Identification of Patients with Adverse Pulmonary Embolism Outcomes

    Article • Diagnostics, January 2022, MDPI AG

    Dr Konstantinos Panagiotis Bartziokas, Chris Kyriakopoulos

  26. Microalbuminuria on admission for acute exacerbation of COPD as a predictor of all-cause mortality and future exacerbations

    Article • Postgraduate Medical Journal, December 2021, BMJ

    Chris Kyriakopoulos, Dr Konstantinos Panagiotis Bartziokas

  27. Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler® Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study

    Article • Journal of Personalized Medicine, November 2021, MDPI AG

    Chris Kyriakopoulos, Dr Konstantinos Panagiotis Bartziokas

  28. Tocilizumab administration for the treatment of hospitalized patients with COVID ‐19: A systematic review and meta‐analysis

    Article • Respirology, October 2021, Wiley

    Chris Kyriakopoulos

  29. The role of uric acid to creatinine ratio as predictor marker during pulmonary embolism

    Article • September 2021, European Respiratory Society (ERS)

    Dr Konstantinos Panagiotis Bartziokas, Chris Kyriakopoulos

  30. The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease

    Article • September 2021, European Respiratory Society (ERS)

    Dr Konstantinos Panagiotis Bartziokas, Chris Kyriakopoulos

  31. Automated detection of cough events with a Smartphone

    Article • September 2021, European Respiratory Society (ERS)

    Konstantinos Tatsis, Chris Kyriakopoulos

  32. Late Breaking Abstract - Tocilizumab administration for the treatment of hospitalised patients with COVID-19: A systematic review and meta-analysis

    Article • September 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  33. Biomarkers model for prediction of hospitalisation duration and pulmonary embolism outcome

    Article • September 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  34. Prothrombotic state in patients with stable COPD: an observational study

    Article • ERJ Open Research, August 2021, European Respiratory Society (ERS)

    Athanasios Konstantinidis, Chris Kyriakopoulos

  35. Hypercoagulable State in COPD-A Comprehensive Literature Review

    Article • Diagnostics, August 2021, MDPI AG

    Chris Kyriakopoulos

  36. Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study

    Article • BMC Pulmonary Medicine, July 2021, Springer Science + Business Media

    Chris Kyriakopoulos

  37. Achievement of High Quality Home Spirometry in Patients with Asthma: The NuvoAir Platform

    Article • May 2021, American Thoracic Society

    Chris Kyriakopoulos

  38. Reduction in Hospitalizations for Respiratory Diseases during the First COVID-19 Wave in Greece

    Article • Respiration, April 2021, Karger Publishers

    Chris Kyriakopoulos

  39. Endothelial injury in Chronic Obstructive Pulmonary Disease assessed by microalbuminuria (MAB) and von Willebrand factor levels and activity

    Article • March 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  40. The role of microalbuminuria (MAB) in patients admitted for an Acute COPD Exacerbation (AECOPD)

    Article • March 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  41. Hypercoagulability in patients with stable COPD assessed by coagulation factor levels

    Article • March 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  42. A 68-year-old man with haemoptysis and extensive ipsilateral lung infiltrates

    Article • Breathe, March 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  43. Corticosteroids in COVID-19: one size does not fit all

    Article • European Respiratory Journal, February 2021, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas, Chris Kyriakopoulos

  44. A direct adverse effect of smoking

    Article • Respiratory Medicine Case Reports, January 2021, Elsevier

    Chris Kyriakopoulos

  45. Systematic Review and Meta-Analysis of Tocilizumab Administration for the Treatment of Hospitalised Patients with COVID-19

    Article • SSRN Electronic Journal, January 2021, Elsevier

    Chris Kyriakopoulos

  46. Legionella pneumonia presenting with reverse halo sign

    Article • September 2020, Scientific Scholar

    Chris Kyriakopoulos

  47. Identification and treatment of T2-low asthma in the era of biologics

    Article • ERJ Open Research, September 2020, European Respiratory Society (ERS)

    Chris Kyriakopoulos, Dr. Konstantinos Kostikas, Dr Konstantinos Panagiotis Bartziokas

  48. Endothelial injury in COPD assessed by microalbuminuria (MAB) and von Willebrand factor levels (vWf:Ag) and activity (vWf:Ac)

    Article • September 2020, European Respiratory Society (ERS)

    christos Chronis , Chris Kyriakopoulos

  49. Hypercoagulability in patients with stable COPD assessed by coagulation factor levels

    Article • September 2020, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  50. Primary Pulmonary Malignant Melanoma: Report of an Important Entity and Literature Review

    Article • Case Reports in Oncological Medicine, January 2017, Hindawi Publishing Corporation

    Professor Stergios Boussios, Chris Kyriakopoulos

  51. Pentamidine

    Article • Reactions Weekly, January 1994, Springer Science + Business Media

    Chris Kyriakopoulos